Try a new search

Format these results:

Searched for:

school:SOM

Department/Unit:Child and Adolescent Psychiatry

Total Results:

11202


Re-imagining Early Childhood Education and School Readiness for Children and Families of Color in the Time of COVID-19 and Beyond [Editorial]

Kerker, Bonnie D; Rojas, Natalia M; Dawson-McClure, Spring; Gonzalez, Cristina
High quality and culturally responsive early childhood education and care (ECEC) for young children before kindergarten is seen as a way to ensure that all children enter school ready to learn. ECEC is even more crucial in the context of recovery from the COVID-19 pandemic and the disproportionate burden of trauma and stress borne by families of color in disinvested neighborhoods. Remote learning and repeated disruptions to in-person instruction as protocols shifted during waves of the pandemic placed an extra strain on families, and may have increased educational disparities in the U.S. Taken together, these challenges have implications for children's school readiness due to their impact on opportunities for learning at home and in the classroom. This paper explores how ECEC programs can be strengthened to better meet children's needs, and ways in which future research can shed light on these important issues.
PMID: 36646660
ISSN: 2168-6602
CID: 5410632

Performance of spiral UTE-MRI of the lung in post-COVID patients

Fauveau, Valentin; Jacobi, Adam; Bernheim, Adam; Chung, Michael; Benkert, Thomas; Fayad, Zahi A; Feng, Li
Patients recovered from COVID-19 may develop long-COVID symptoms in the lung. For this patient population (post-COVID patients), they may benefit from longitudinal, radiation-free lung MRI exams for monitoring lung lesion development and progression. The purpose of this study was to investigate the performance of a spiral ultrashort echo time MRI sequence (Spiral-VIBE-UTE) in a cohort of post-COVID patients in comparison with CT and to compare image quality obtained using different spiral MRI acquisition protocols. Lung MRI was performed in 36 post-COVID patients with different acquisition protocols, including different spiral sampling reordering schemes (line in partition or partition in line) and different breath-hold positions (inspiration or expiration). Three experienced chest radiologists independently scored all the MR images for different pulmonary structures. Lung MR images from spiral acquisition protocol that received the highest image quality scores were also compared against corresponding CT images in 27 patients for evaluating diagnostic image quality and lesion identification. Spiral-VIBE-UTE MRI acquired with the line in partition reordering scheme in an inspiratory breath-holding position achieved the highest image quality scores (score range = 2.17-3.69) compared to others (score range = 1.7-3.29). Compared to corresponding chest CT images, three readers found that 81.5% (22 out of 27), 81.5% (22 out of 27) and 37% (10 out of 27) of the MR images were useful, respectively. Meanwhile, they all agreed that MRI could identify significant lesions in the lungs. The Spiral-VIBE-UTE sequence allows for fast imaging of the lung in a single breath hold. It could be a valuable tool for lung imaging without radiation and could provide great value for managing different lung diseases including assessment of post-COVID lesions.
PMCID:9731813
PMID: 36503014
ISSN: 1873-5894
CID: 5417562

Author Correction: Global dietary quality in 185 countries from 1990 to 2018 show wide differences by nation, age, education, and urbanicity (Nature Food, (2022), 3, 9, (694-702), 10.1038/s43016-022-00594-9)

Miller, V; Webb, P; Cudhea, F; Shi, P; Zhang, J; Reedy, J; Erndt-Marino, J; Coates, J; Mozaffarian, D; Bas, M; Ali, J H; Abumweis, S; Krishnan, A; Misra, P; Hwalla, N C; Janakiram, C; Liputo, N I; Musaiger, A; Pourfarzi, F; Alam, I; DeRidder, K; Termote, C; Memon, A; Turrini, A; Lupotto, E; Piccinelli, R; Sette, S; Anzid, K; Vossenaar, M; Mazumdar, P; Rached, I; Rovirosa, A; Zapata, M E; Asayehu, T T; Oduor, F; Boedecker, J; Aluso, L; Ortiz-Ulloa, J; Meenakshi, J V; Castro, M; Grosso, G; Waskiewicz, A; Khan, U S; Thanopoulou, A; Malekzadeh, R; Calleja, N; Ocke, M; Etemad, Z; Nsour, M A; Waswa, L M; Nurk, E; Arsenault, J; Lopez-Jaramillo, P; Sibai, A M; Damasceno, A; Arambepola, C; Lopes, C; Severo, M; Lunet, N; Torres, D; Tapanainen, H; Lindstrom, J; Virtanen, S; Palacios, C; Roos, E; Agdeppa, I A; Desnacido, J; Capanzana, M; Misra, A; Khouw, I; Ng, S A; Delgado, E G; Caballero, M; Otero, J; Lee, H -J; Koksal, E; Guessous, I; Lachat, C; De, Henauw S; Rahbar, A R; Tedstone, A; Naska, A; Mathee, A; Ling, A; Tedla, B; Hopping, B; Ginnela, B; Leclercq, C; Duante, C; Haerpfer, C; Hotz, C; Pitsavos, C; Rehm, C; van, Oosterhout C; Cerdena, C; Bradshaw, D; Trichopoulos, D; Gauci, D; Fernando, D; Sygnowska, E; Vartiainen, E; Farzadfar, F; Zajkas, G; Swan, G; Ma, G; Pekcan, G; Ibrahim, H M; Sinkko, H; Barbieri, H E; Sioen, I; Myhre, J; Gaspoz, J -M; Odenkirk, J; Bundhamcharoen, K; Nelis, K; Zarina, K; Biro, L; Johansson, L; Steingrimsdottir, L; Riley, L; Yap, M; Inoue, M; Szabo, M; Ovaskainen, M -L; Lee, M -S; Chan, M F; Cowan, M; Kandiah, M; Kally, O; Jonsdottir, O; Palmer, P; Vollenweider, P; Orfanos, P; Asciak, R; Templeton, R; Don, R; Yaakub, R; Selamat, R; Yusof, S; Al-Zenki, S; Hung, S -Y; Beer-Borst, S; Wu, S; Lukito, W; Hadden, W; Becker, W; Cao, X; Ma, Y; Lai, Y; Hjdaud, Z; Garriguet, D; Ali, J; Gravel, R; Tao, T; Veerman, J L; Chiplonkar, S; Arici, M; Ngoan, L T; Panagiotakos, D; Li, Y; Trichopoulou, A; Barengo, N; Khadilkar, A; Ekbote, V; Mohammadifard, N; Kovalskys, I; Laxmaiah, A; Rachakulla, H; Rajkumar, H; Meshram, I; Avula, L; Arlappa, N; Hemalatha, R; lacoviello, L; Bonaccio, M; Costanzo, S; Martin-Prevel, Y; Castetbon, K; Jitnarin, N; Hsieh, Y -T; Olivares, S; Tejeda, G; Hadziomeragic, A; de, Moura Souza A; Pan, W -H; Huybrechts, I; de, Brauw A; Moursi, M; Maghroun, M; Zeba, A N; Sarrafzadegan, N; Keinan-Boker, L; Goldsmith, R; Shimony, T; Jordan, I; Mastiholi, S C; Mwangi, M; Kombe, Y; Bukania, Z; Alissa, E; Al-Daghri, N; Sabico, S; Gulliford, M; Diba, T S; Oh, K; Kweon, S; Park, S; Cho, Y; Al-Hooti, S; Luangphaxay, C; Douangvichit, D; Siengsounthone, L; Marques-Vidal, P; Rybak, C; Luke, A; Rojroongwasinkul, N; Piaseu, N; Sundram, K; Baykova, D; Abedi, P; Fadzil, F; Bukhary, N B I; Bovet, P; Sandjaja, S; Chen, Y; Sawada, N; Tsugane, S; Rangelova, L; Petrova, S; Duleva, V; Lindroos, A K; Sipinen, J P; Moraeus, L; Bergman, P; Siamusantu, W; Szponar, L; Chang, H -Y; Sekiyama, M; Nagalla, B; Polasa, K; Boindala, S; Le, Nguyen Bao K; El, Ati J; Illescas-Zarate, D; Sanchez-Romero, L M; Silva, I R; Dommarco, J R; Barquera, S; Rodriguez-Ramirez, S; Ikeda, N; Zaghloul, S; Houshiar-rad, A; Mohammadi-Nasrabadi, F; Abdollahi, M; Chuah, K -A; Mahdy, Z A; Eldridge, A; Ding, E L; Kruger, H; Henjum, S; Fernandez, A; Suarez-Ortegon, M F; Al-Hamad, N; Janska, V; Tayyem, R; Mirmiran, P; Kelishadi, R; Lemming, E W; Richter, A; Mensink, G; Wieler, L; Hoffman, D; Salanave, B; Kim, C -I; Kuriyan-Raj, R; Swaminathan, S; Dastgiri, S; Vaask, S; Karupaiah, T; Zohoori, F V; Esteghamati, A; Noshad, S; Hashemian, M; Mwaniki, E; Yakes-Jimenez, E; Chileshe, J; Mwanza, S; Marques, L L; Preston, A M; Aguero, S D; Oleas, M; Posada, L; Ochoa, A; Shamsuddin, K; Shariff, Z M; Jan, Bin Jan Mohamed H; Manan, W; Nicolau, A; Tudorie, C; Poh, B K; Abbott, P; Pakseresht, M; Sharma, S; Strand, T; Alexy, U; Nothlings, U; Jan, Carmikle; Brown, K; Koster, J; Waidyatilaka, I; Lanerolle, P; Jayawardena, R; Long, J M; Hambidge, K M; Krebs, N F; Haque, A; Keding, G B; Korkalo, L; Erkkola, M; Freese, R; Eleraky, L; Stuetz, W; Thorsdottir, I; Gunnarsdottir, I; Serra-Majem, L; Moy, F M; Anderson, S; Jeewon, R; Zugravu, C A; Adair, L; Ng, S W; Skeaff, S; Marchioni, D; Fisberg, R; Henry, C; Ersino, G; Zello, G; Meyer, A; Elmadfa, I; Mitchell, C; Balfour, D; Geleijnse, J M; Manary, M; Nikiema, L; El-kour, T; Mirzaei, M; Hakeem, R
EMBASE:2021228968
ISSN: 2662-1355
CID: 5513812

Beyond Diagnosis: Formulation-Storytelling and Maps [Editorial]

Hoyos, Carlos; Cortese, Samuele
In this Clinical Perspective, we argue that, at least for some patients, formulation, rather than diagnosis, should be the cornerstone in clinical practice in child and adolescent psychiatry. As opposed to a rigid, tick-the-box approach to formulation, we advocate for a conceptualization of formulation that moves the practice of (child and adolescent) psychiatry into the realm of storytelling and construction of narratives. We suggest that the use of role playing and narrative art forms, such as novels or films, during the training may contribute to develop the skills in telling a story (ie, the formulation) about/to a patient.
PMID: 35779697
ISSN: 1527-5418
CID: 5281542

Candidate diagnostic biomarkers for neurodevelopmental disorders in children and adolescents: a systematic review

Cortese, Samuele; Solmi, Marco; Michelini, Giorgia; Bellato, Alessio; Blanner, Christina; Canozzi, Andrea; Eudave, Luis; Farhat, Luis C; Højlund, Mikkel; Köhler-Forsberg, Ole; Leffa, Douglas Teixeira; Rohde, Christopher; de Pablo, Gonzalo Salazar; Vita, Giovanni; Wesselhoeft, Rikke; Martin, Joanna; Baumeister, Sarah; Bozhilova, Natali S; Carlisi, Christina O; Leno, Virginia Carter; Floris, Dorothea L; Holz, Nathalie E; Kraaijenvanger, Eline J; Sacu, Seda; Vainieri, Isabella; Ostuzzi, Giovanni; Barbui, Corrado; Correll, Christoph U
Neurodevelopmental disorders - including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, communication disorders, intellectual disability, motor disorders, specific learning disorders, and tic disorders - manifest themselves early in development. Valid, reliable and broadly usable biomarkers supporting a timely diagnosis of these disorders would be highly relevant from a clinical and public health standpoint. We conducted the first systematic review of studies on candidate diagnostic biomarkers for these disorders in children and adolescents. We searched Medline and Embase + Embase Classic with terms relating to biomarkers until April 6, 2022, and conducted additional targeted searches for genome-wide association studies (GWAS) and neuroimaging or neurophysiological studies carried out by international consortia. We considered a candidate biomarker as promising if it was reported in at least two independent studies providing evidence of sensitivity and specificity of at least 80%. After screening 10,625 references, we retained 780 studies (374 biochemical, 203 neuroimaging, 133 neurophysiological and 65 neuropsychological studies, and five GWAS), including a total of approximately 120,000 cases and 176,000 controls. While the majority of the studies focused simply on associations, we could not find any biomarker for which there was evidence - from two or more studies from independent research groups, with results going into the same direction - of specificity and sensitivity of at least 80%. Other important metrics to assess the validity of a candidate biomarker, such as positive predictive value and negative predictive value, were infrequently reported. Limitations of the currently available studies include mostly small sample size, heterogeneous approaches and candidate biomarker targets, undue focus on single instead of joint biomarker signatures, and incomplete accounting for potential confounding factors. Future multivariable and multi-level approaches may be best suited to find valid candidate biomarkers, which will then need to be validated in external, independent samples and then, importantly, tested in terms of feasibility and cost-effectiveness, before they can be implemented in daily clinical practice.
PMCID:9840506
PMID: 36640395
ISSN: 1723-8617
CID: 5470462

Innovations in Neuropsychology: Future Applications in Neurosurgical Patient Care

McLean, Erin; Cornwell, Melinda A; Bender, H Allison; Sacks-Zimmerman, Amanda; Mandelbaum, Sarah; Koay, Jun Min; Raja, Noreen; Kohn, Aviva; Meli, Gabrielle; Spat-Lemus, Jessica
Over the last century, collaboration between clinical neuropsychologists and neurosurgeons has advanced the state of the science in both disciplines. These advances have provided the field of neuropsychology with many opportunities for innovation in the care of patients prior to, during, and following neurosurgical intervention. Beyond giving a general overview of how present-day advances in technology are being applied in the practice of neuropsychology within a neurological surgery department, this article outlines new developments that are currently unfolding. Improvements in remote platform, computer interface, "real-time" analytics, mobile devices, and immersive virtual reality have the capacity to increase the customization, precision, and accessibility of neuropsychological services. In doing so, such innovations have the potential to improve outcomes and ameliorate health care disparities.
PMID: 36782427
ISSN: 1878-8769
CID: 5791232

The Impact of the COVID-19 Pandemic on Adolescents: An Opportunity to Build Resilient Systems [Editorial]

Nadeem, Erum; R Van Meter, Anna
The impact of the COVID-19 pandemic on adolescents is significant. Educational progress and mental health, in particular, have been negatively affected. Among youth from vulnerable communities, pre-existing academic and health disparities have been exacerbated. Youth outcomes are often attributed to individual resilience - or lack thereof; in this paper, we describe how failure to adapt and effectively cope at the system level (ie, lack of system resilience) is implicated in the current dual educational and mental crisis. We describe opportunities to make our systems more nimble and better-equipped to support youth moving forward.
PMID: 36646661
ISSN: 2168-6602
CID: 5410642

Impact of mental disorders on clinical outcomes of physical diseases: an umbrella review assessing population attributable fraction and generalized impact fraction

Dragioti, Elena; Radua, Joaquim; Solmi, Marco; Gosling, Corentin J; Oliver, Dominic; Lascialfari, Filippo; Ahmed, Muhammad; Cortese, Samuele; Estradé, Andrés; Arrondo, Gonzalo; Gouva, Mary; Fornaro, Michele; Batiridou, Agapi; Dimou, Konstantina; Tsartsalis, Dimitrios; Carvalho, Andre F; Shin, Jae Il; Berk, Michael; Stringhini, Silvia; Correll, Christoph U; Fusar-Poli, Paolo
Empirical evidence indicates a significant bidirectional association between mental disorders and physical diseases, but the prospective impact of men-tal disorders on clinical outcomes of physical diseases has not been comprehensively outlined. In this PRISMA- and COSMOS-E-compliant umbrella review, we searched PubMed, PsycINFO, Embase, and Joanna Briggs Institute Database of Systematic Reviews and Implementation Reports, up to March 15, 2022, to identify systematic reviews with meta-analysis that examined the prospective association between any mental disorder and clinical outcomes of physical diseases. Primary outcomes were disease-specific mortality and all-cause mortality. Secondary outcomes were disease-specific incidence, functioning and/or disability, symptom severity, quality of life, recurrence or progression, major cardiac events, and treatment-related outcomes. Additional inclusion criteria were further applied to primary studies. Random effect models were employed, along with I2 statistic, 95% prediction intervals, small-study effects test, excess significance bias test, and risk of bias (ROBIS) assessment. Associations were classified into five credibility classes of evidence (I to IV and non-significant) according to established criteria, complemented by sensitivity and subgroup analyses to examine the robustness of the main analysis. Statistical analysis was performed using a new package for conducting umbrella reviews (https://metaumbrella.org). Population attributable fraction (PAF) and generalized impact fraction (GIF) were then calculated for class I-III associations. Forty-seven systematic reviews with meta-analysis, encompassing 251 non-overlapping primary studies and reporting 74 associations, were included (68% were at low risk of bias at the ROBIS assessment). Altogether, 43 primary outcomes (disease-specific mortality: n=17; all-cause mortality: n=26) and 31 secondary outcomes were investigated. Although 72% of associations were statistically significant (p<0.05), only two showed convincing (class I) evidence: that between depressive disorders and all-cause mortality in patients with heart failure (hazard ratio, HR=1.44, 95% CI: 1.26-1.65), and that between schizophrenia and cardiovascular mortality in patients with cardiovascular diseases (risk ratio, RR=1.54, 95% CI: 1.36-1.75). Six associations showed highly suggestive (class II) evidence: those between depressive disorders and all-cause mortality in patients with diabetes mellitus (HR=2.84, 95% CI: 2.00-4.03) and with kidney failure (HR=1.41, 95% CI: 1.31-1.51); that between depressive disorders and major cardiac events in patients with myocardial infarction (odds ratio, OR=1.52, 95% CI: 1.36-1.70); that between depressive disorders and dementia in patients with diabetes mellitus (HR=2.11, 95% CI: 1.77-2.52); that between alcohol use disorder and decompensated liver cirrhosis in patients with hepatitis C (RR=3.15, 95% CI: 2.87-3.46); and that between schizophrenia and cancer mortality in patients with cancer (standardized mean ratio, SMR=1.74, 95% CI: 1.41-2.15). Sensitivity/subgroup analyses confirmed these results. The largest PAFs were 30.56% (95% CI: 27.67-33.49) for alcohol use disorder and decompensated liver cirrhosis in patients with hepatitis C, 26.81% (95% CI: 16.61-37.67) for depressive disorders and all-cause mortality in patients with diabetes mellitus, 13.68% (95% CI: 9.87-17.58) for depressive disorders and major cardiac events in patients with myocardial infarction, 11.99% (95% CI: 8.29-15.84) for schizophrenia and cardiovascular mortality in patients with cardiovascular diseases, and 11.59% (95% CI: 9.09-14.14) for depressive disorders and all-cause mortality in patients with kidney failure. The GIFs confirmed the preventive capacity of these associations. This umbrella review demonstrates that mental disorders increase the risk of a poor clinical outcome in several physical diseases. Prevention targeting mental disorders - particularly alcohol use disorders, depressive disorders, and schizophrenia - can reduce the incidence of adverse clinical outcomes in people with physical diseases. These findings can inform clinical practice and trans-speciality preventive approaches cutting across psychiatric and somatic medicine.
PMCID:9840513
PMID: 36640414
ISSN: 1723-8617
CID: 5470482

Dietary quality and diet-related factors among adult females of reproductive age with and without disabilities participating in the National Health and Nutrition Examination Surveys, 2013 - 2018

Deierlein, Andrea L; Litvak, Jaqueline; Stein, Cheryl R
BACKGROUND:Adult females of reproductive age (18-44 years) with disabilities have higher rates of health-risk behaviors and chronic conditions compared to their counterparts without disabilities; however, there is limited examination of diet. OBJECTIVE:To examine associations of self-reported disability status with diet quality and diet-related factors. DESIGN/METHODS:Cross-sectional data were from the National Health and Nutrition Examination Surveys, 2013-2018. PARTICIPANTS/SETTING/METHODS:Adult females aged 18-44 years were included. Disability was defined as serious difficulty hearing, seeing, concentrating, walking, dressing, and/or running errands due to physical, mental, or emotional conditions. MAIN OUTCOME MEASURES/METHODS:The Healthy Eating Index (HEI)-2015 assessed diet quality. Diet-related factors included self-rated diet healthfulness, meal characteristics, food security, and food assistance programs. STATISTICAL ANALYSIS/METHODS:Multivariable linear regression estimated differences in HEI-2015 scores for a given day and multivariable Poisson regression estimated adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) of diet-related factors by disability status. RESULTS:Of 3,579 adult females, 557 (16%) reported any disabilities, 207 (6%) of whom reported having two or more types of disabilities. Differences in mean HEI-2015 scores for a given day were one third to half of a point lower for fruits, total protein foods, and seafood/plant proteins among females with two or more types of disabilities compared to those without disabilities. Females with any disabilities were more likely to rate their diet as poor, have low food security, participate in food assistance programs, and consume frozen foods/pizza compared to those without disabilities (aPR ranged from 1.35 to 1.93); they were less likely to be the main food planner/preparer or shopper for their households. CONCLUSIONS:Some indicators of diet quality and diet-related factors differed between adult females with and without disabilities. Further investigation of dietary intakes and behaviors, as well as access to and availability of healthy foods, among females with disabilities is necessary.
PMID: 35872244
ISSN: 2212-2672
CID: 5276122

Development of Atypical Neuroleptic Malignant Syndrome After Treatment of Cocaine Intoxication: A Case Report and Literature Review [Case Report]

Miller, Maxwell; Zezetko, Alisa; Satodiya, Ritvij
Neuroleptic malignant syndrome (NMS) is a life-threatening condition classically associated with the use of antipsychotic medications. NMS commonly presents with initial mental status changes, followed by muscle rigidity, fever, and eventual dysautonomia. Cocaine intoxication can present with symptoms that are very similar to those found in NMS, making differentiating the two disorders challenging. We present the case of a 28-year-old female with a history of cocaine use disorder who presented with acute cocaine intoxication. She had severe agitation associated with her intoxication, requiring the use of antipsychotic medications. Subsequently, she developed atypical NMS from abrupt dopamine withdrawal after receiving the antipsychotics. Although overlapping dopamine pathways between cocaine use and NMS could deter one from this practice and guidelines recommend against it, antipsychotics are routinely used in the emergency setting for cocaine-associated agitation. This case highlights the need for a more standardized treatment protocol, provides an explanation of why treating cocaine intoxication with antipsychotics is inappropriate, and suggests that chronic cocaine users may be more prone to NMS in this scenario. Furthermore, this is a unique case because it describes atypical NMS in the context of cocaine intoxication, chronic cocaine use, and administration of antipsychotics to an antipsychotic-naïve patient.
PMCID:10058510
PMID: 37007397
ISSN: 2168-8184
CID: 5607552